Device
Magstim Rapid2
Magstim Rapid2 is a medical device with 3 clinical trials. Currently 2 active trials ongoing.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Active Trials
2(67%)
Phase Distribution
Ph not_applicable
2
67%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
0.0%
0 of 1 finished
Non-Completion Rate
100.0%
1 ended early
Currently Active
2
trials recruiting
Total Trials
3
all time
Status Distribution
Active(2)
Terminated(1)
Detailed Status
Recruiting2
Withdrawn1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
2
Success Rate
N/A
Most Advanced
N/A
Trials by Phase
N/A2 (100.0%)
Trials by Status
withdrawn133%
recruiting267%
Recent Activity
2 active trials
Showing 3 of 3
recruiting
The Modulatory Effect of Female Sex Hormones on Spinal Neuroplasticity
NCT06656819
recruitingnot_applicable
RTMS and Steroid Joint Steroid Injection in Chronic Spinal Pain
NCT05840354
withdrawnnot_applicable
Non-Invasive TMS Neuromodulation for Enduring Balance & Locomotion Restoration in Parkinson's Disease
NCT02875041
Clinical Trials (3)
Showing 3 of 3 trials
NCT06656819
The Modulatory Effect of Female Sex Hormones on Spinal Neuroplasticity
NCT05840354Not Applicable
RTMS and Steroid Joint Steroid Injection in Chronic Spinal Pain
NCT02875041Not Applicable
Non-Invasive TMS Neuromodulation for Enduring Balance & Locomotion Restoration in Parkinson's Disease
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3